Content about Antibiotics

March 10, 2014

The majority of pediatric bacterial infections that cause severe diarrhea and are potentially life-threatening occur among children who recently took antibiotics prescribed by doctors for other conditions, according to a new study by the Centers for Disease Control and Prevention published this week in Pediatrics.

NEW YORK — The majority of pediatric bacterial infections that cause severe diarrhea and are potentially life-threatening occur among children who recently took antibiotics prescribed by doctors for other conditions, according to a new study by the Centers for Disease Control and Prevention published this week in Pediatrics.

March 3, 2014

Last week, more than 30 organizations — including the American Medical Association, Infectious Diseases Society of America and Pew Charitable Trusts — urged Congressional leaders to strengthen the labeling requirements for drugs approved under the proposed Antibiotic Development to Advance Patient Treatment Act of 2013 (ADAPT Act) limited population approval pathway, which will streamline regulatory approval for antibiotics.

WASHINGTON — Last week, more than 30 organizations  — including the American Medical Association, Infectious Diseases Society of America and Pew Charitable Trusts — urged Congressional leaders to strengthen the labeling requirements for drugs approved under the proposed Antibiotic Development to Advance Patient Treatment Act of 2013 (ADAPT Act) limited population approval pathway, which will streamline regulatory approval for antibiotics. 

January 16, 2014

A faculty member at Southern Illinois University Edwardsville has been awarded a United States patent for an invention that tackles bacterial contamination.

EDWARDSVILLE, Ill. — Dr. Ronald Worthington, associate professor of pharmaceutical sciences at the School of Pharmacy at Southern Illinois University Edwardsville, obtained U.S. Patent No. 8,563,293 for his invention to protect against bacterial contamination. 

December 16, 2013

The Food and Drug Administration may require makers of antibacterial soaps to perform clinical trials to show their products are better at preventing infections and disease than ordinary soaps.

SILVER SPRING, Md. — The Food and Drug Administration may require makers of antibacterial soaps to perform clinical trials to show their products are better at preventing infections and disease than ordinary soaps, part of a larger effort by the agency to ensure the safety and efficacy of antibacterial products and slow down the rise of antibiotic-resistant bacteria.

December 11, 2013

The Food and Drug Administration is planning to limit the use of antimicrobials in food animals in an effort to stem the rise of antibiotic-resistant bacteria, the agency said Wednesday.

SILVER SPRING, Md. – The Food and Drug Administration is planning to limit the use of antimicrobials in food animals in an effort to stem the rise of antibiotic-resistant bacteria, the agency said Wednesday.

October 7, 2013

Doctors have continued prescribing antibiotics for mild conditions that don't require them despite decades of efforts by government authorities to discourage the practice, according to a new study.

NEW YORK — Doctors have continued prescribing antibiotics for mild conditions that don't require them despite decades of efforts by government authorities to discourage the practice, according to a new study.

October 2, 2013

Outcomes improve and there can be significant cost savings when infusion pharmacists monitor patients receiving home-based infusion services and intervene when dose adjustments are necessary, according to a Walgreens outcomes analysis study being presented Wednesday at IDWeek 2013 in San Francisco.

DEERFIELD, Ill. — Outcomes improve, and there can be significant cost savings when infusion pharmacists monitor patients receiving home-based infusion services and intervene when dose adjustments are necessary, according to a Walgreens outcomes analysis study being presented Wednesday at IDWeek 2013 in San Francisco.

September 17, 2013

Antibiotic-resistant bacteria sicken more than 2 million people per year and kill at least 23,000, according to a new study by the Centers for Disease Control and Prevention.

ATLANTA — Antibiotic-resistant bacteria sicken more than 2 million people per year and kill at least 23,000, according to a new study by the Centers for Disease Control and Prevention.

And the costs go beyond human health and life. According to a study by Tufts University, direct healthcare costs and costs to society for lost productivity from the infections could be as high as $55 billion per year.

September 13, 2013

Cubist has completed its purchase of Trius Therapeutics, Cubist said.

LEXINGTON, Mass. — Cubist has completed its purchase of Trius Therapeutics, Cubist said.

The $704 million acquisition will give Cubist control of the drug tedizolid phosphate, an experimental drug that it said had the potential to treat resistant infections. Trius ceased to be traded on the NASDAQ earlier this week.

September 9, 2013

Procter & Gamble is working to eliminate two chemicals — triclosan and diethyl phthalate — from its products by 2014, the manufacturer has stated on its website.

CINCINNATI — Procter & Gamble is working to eliminate two chemicals — triclosan and diethyl phthalate — from its products by 2014, the manufacturer has stated on its website.

According to P&G, triclosan is an antimicrobal ingredient that slows or stops the growth of germs, such as bacteria and mildew. P&G stated that it only uses triclosan in antibacterial dish soap, professional hand soap and a few personal care products.

June 20, 2013

CVS Caremark has announced that its Pharmacy Advisor program is featured in the national report issued by the IMS Institute for Healthcare Informatics report released this week.

WOONSOCKET, R.I. — CVS Caremark has announced that its Pharmacy Advisor program is featured in the national report issued by the IMS Institute for Healthcare Informatics report released this week.

As reported by Drug Store News, The IMS Institute for Healthcare Informatics found that better adherence, more careful prescribing of antibiotics and increased generic use could reduce the country's total annual health expenditures by 8%.

June 19, 2013

More responsible use of drugs could save the U.S. healthcare system more than $200 billion per year, according to a new study by the research arm of IMS Health.

PARSIPPANY, N.J. — More responsible use of drugs could save the U.S. healthcare system more than $200 billion per year, according to a new study by the research arm of IMS Health.

June 19, 2013

A large majority of Americans are taking prescription drugs, according to a new study by the Mayo Clinic.

ROCHESTER, Minn. — A large majority of Americans are taking prescription drugs, according to a new study by the Mayo Clinic.

The study, published online in the journal Mayo Clinic Proceedings, found that nearly 70% of Americans are taking at least one drug, and more than half are taking two. Most of the drugs are antibiotics, antidepressants and opioid painkillers. Researchers said the data, which came from the Rochester Epidemiology Project, would be valuable because it would give insight into prescribing practices.

June 10, 2013

Are retail clinics a fad or a permanent and viable part of the healthcare landscape?

That was the question explored by health experts at a web-based summit April 25, presented by the Rand Corp. and the University of Pittsburgh.

Are retail clinics a fad or a permanent and viable part of the healthcare landscape?

January 10, 2013

A recent study found that poor heath literacy among Latino parents is associated with incorrect beliefs on the proper use of antibiotics, particularly for upper respiratory infections, which can lead to an increase in antimicrobial resistance.

NEW YORK — A recent study found that poor heath literacy among Latino parents is associated with incorrect beliefs on the proper use of antibiotics, particularly for upper respiratory infections, which can lead to an increase in antimicrobial resistance.

December 20, 2012

Actavis has donated $200,000 worth of medicines to help people affected by Hurricane Sandy, a charity organization said Thursday.

STAMFORD, Conn. — Actavis has donated $200,000 worth of medicines to help people affected by Hurricane Sandy, a charity organization said Thursday.

AmeriCares announced that it donated the antibiotics, pediatric medicines and other drugs to healthcare providers helping affected families in New York and New Jersey within days of the storm. Actavis was acquired earlier this year by Watson Pharmaceuticals.

December 17, 2012

The Food and Drug Administration has approved a new biotech drug from GlaxoSmithKline for anthrax, the drug maker said.

LONDON — The Food and Drug Administration has approved a new biotech drug from GlaxoSmithKline for anthrax, the drug maker said.

GSK announced the approval of raxibacumab for adults and children who have inhaled Bacillus anthracis. The drug is designed for combination with antibiotics and for preventing inhalational anthrax when alternative therapies aren't available. The drug is the result of a project that Human Genome Sciences, now owned by GSK, began working on in 2001 in response to terrorist anthrax attacks in the United States.

September 24, 2012

The Food and Drug Administration is creating a new task force to support the development of new drugs for bacterial infections, the agency said Monday.

SILVER SPRING, Md. — The Food and Drug Administration is creating a new task force to support the development of new drugs for bacterial infections, the agency said Monday.

The FDA said the Antibacterial Drug Development Task Force would assist in developing and revising guidance related to development of antibiotics, as required by the Generating Antibiotic Incentives Now Title of the FDA Safety and Innovation Act, which president Barack Obama signed into law on July 9.

September 10, 2012

A drug maker and medical research institute will work together to identify new treatments for bacterial and viral infections.

CAMBRIDGE, Mass. — A drug maker and medical research institute will work together to identify new treatments for bacterial and viral infections.

AstraZeneca and the Broad Institute, owned jointly by Harvard University and MIT, announced Monday that they would collaborate for two years to develop medicines to treat severe infections, saying the identification of high-quality chemicals for the development of new drugs was a significant challenge. The two will use the Broad Institute's collection of 100,000 chemicals known as diversity-oriented synthesis, or DOS compounds.

September 10, 2012

Minor, uncomplicated wounds, such as the typical cuts and scrapes of childhood, are less likely to become infected when kept clean and moist and treated with topical antibiotics, according to a literature review published online Friday in the Annals of Emergency Medicine, the peer-reviewed scientific journal for the American College of Emergency Physicians.

WASHINGTON — Minor, uncomplicated wounds, such as the typical cuts and scrapes of childhood, are less likely to become infected when kept clean and moist and treated with topical antibiotics, according to a literature review published online Friday in the Annals of Emergency Medicine, the peer-reviewed scientific journal for the American College of Emergency Physicians.

July 2, 2012

Grocery chain ShopRite is offering free prenatal vitamins to further help shoppers live healthier lives and prepare for a healthy baby.

KEASBEY, N.J. — Grocery chain ShopRite is offering free prenatal vitamins to further help shoppers live healthier lives and prepare for a healthy baby.

ShopRite customers can receive a free 30-day supply of Prenatal Plus or Prenatal Plus FE vitamins with a valid prescription. ShopRite also offers free 30-day supplies of select generic diabetes drugs and free 14-day supplies of select generic antibiotics. Other generic prescriptions start as low as $3.99 for a 30-day supply.

There are no membership fees or insurance required to benefit from these savings.

June 14, 2012

A significant growth opportunity for independent pharmacy may be in its sales of over-the-counter products, according to a recent white paper published by the Hamacher Resource Group.

WAUKESHA, Wis. — A significant growth opportunity for independent pharmacy may be in its sales of over-the-counter products, according to a recent white paper published by the Hamacher Resource Group. Patient access to pharmacists and their product recommendations contribute to improved OTC performance within independent pharmacy, the report noted.

May 8, 2012

Consumption of probiotics is associated with a reduced risk of antibiotic-associated diarrhea, a common adverse effect of antibiotic use, according to a review and meta-analysis of previous studies published in the May 9 issue of JAMA, the Journal of the American Medical Association.

CHICAGO — Consumption of probiotics is associated with a reduced risk of antibiotic-associated diarrhea, a common adverse effect of antibiotic use, according to a review and meta-analysis of previous studies published in the May 9 issue of JAMA, the Journal of the American Medical Association.

February 13, 2012

Chances are, you didn’t enroll in pharmacy school to count out pills behind a counter. As part of the next generation of clinically driven PharmDs, you’re probably looking for a lot more.

Chances are, you didn’t enroll in pharmacy school to count out pills behind a counter. As part of the next generation of clinically driven PharmDs, you’re probably looking for a lot more.

February 9, 2012

The Food and Drug Administration on Wednesday issued a public warning that the use of proton-pump inhibitors or H2 blockers may be associated with an increased risk of Clostridium difficile–associated diarrhea, or CDAD.

SILVER SPRING, Md. — The Food and Drug Administration on Wednesday issued a public warning that the use of proton-pump inhibitors or H2 blockers may be associated with an increased risk of Clostridium difficile–associated diarrhea, or CDAD.

Patients should immediately contact their healthcare professional and seek care if they take PPIs and develop diarrhea that does not improve, the agency stated.